International Dairy Queen and FountainVest Partners Announce Plans to Open 600 DQ Restaurants in China By 2030
FountainVest Partners will begin expansion by opening 100 DQ restaurants in China this year. MINNEAPOLIS…
FountainVest Partners will begin expansion by opening 100 DQ restaurants in China this year. MINNEAPOLIS…
Global ISV status to enhance Skytap on Azure go-to-market and engineering collaboration with Microsoft to…
– Independent report named InMoment among key vendors for text analytics platforms and applications –…
Growing adoption of Zero Trust principles and corresponding growth in deployments of SDP-based solutions called…
Leader in Embedded Integrations and Low-code Automation Repeats Appearance on Prestigious Industry List, Demonstrating Strong…
SAN MATEO, Calif.–(BUSINESS WIRE)–Upstart (NASDAQ: UPST), a leading artificial intelligence (AI) lending platform, today announced…
New functionality for transdermal products creates a state-of-the-art IVIVE methodology in combination with the GastroPlus…
New hires bring decades’ worth of tech, finance, and marketplace technology experience to TrustToken’s leadership…
TORONTO & DALLAS–(BUSINESS WIRE)–$PINK.V #AI–Perimeter Medical Imaging AI, Inc. (TSX-V:PINK) (OTC:PYNKF) (FSE:4PC) (“Perimeter” or the…
CHARLOTTE, N.C.–(BUSINESS WIRE)–Today, Segra, one of the largest independent fiber infrastructure companies in the Eastern…
New application enables users to build, provision and manage data fabrics within a single environment…
Keith Graham appointed Head of University Program Munich, 10 March 2022 – Codasip, the leader…
Testing program underway for lead product candidate, the Symphony IL-6 Test, in support of an…
PHILADELPHIA, March 10, 2022 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq: FOLD), today announced one oral…
– Initial clinical data for FHD-286 expected in H1’22 and FHD-609 as early as H1’22…
Optimizing vaccine design for Alzheimer’s disease TORONTO, Ontario and CAMBRIDGE, Mass., March 10, 2022 (GLOBE…
– Conference call to be held on March 10, 2022 at 8:30 am ET/1:30 pm…
CAMBRIDGE, Mass., March 10, 2022 (GLOBE NEWSWIRE) — Oncorus, Inc. (Nasdaq: ONCR), a viral immunotherapies…
Positive Phase 3 ROMAN trial of avasopasem for severe oral mucositis met primary and secondary…
DURHAM, N.C., March 10, 2022 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or “the…